Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
申请人:Orentreich Foundation for the Advancement of Science, Inc.
公开号:US20020143039A1
公开(公告)日:2002-10-03
Insulin sensitivity increasing substances (ISIS), including but not limited to D-chiro-inositol, thiazolidinedione and derivatives, and biguanides, are useful in the treatment of hair loss and other disorders of the pilosebaceous apparatus (hirsutism, acne, etc.) associated with conditions of excess insulin and/or insulin resistance. The treatment comprises administering to a mammal, such as a human, at least one ISIS either alone or in combination with at least one agent, such as an androgen receptor blocker (ARB) and/or a steroid enzyme inhibitor or inducer (STI). Additionally, an activity enhancing agent may be included for topical administration.
胰岛素敏感性增加物质(ISIS),包括但不限于D-螺肌醇、噻唑烷二酮及其衍生物和双胍类,可用于治疗与胰岛素过量和/或胰岛素抵抗相关的脱发和其他皮脂腺疾病(多毛症、痤疮等)。治疗方法包括向哺乳动物(如人类)施用至少一种 ISIS,可以单独施用,也可以与至少一种制剂(如雄激素受体阻断剂(ARB)和/或类固醇酶抑制剂或诱导剂(STI))联合施用。此外,还可加入一种活性增强剂,用于局部给药。